Go Pro

Strata Skin Sciences (SSKN) Competitors

Strata Skin Sciences logo
$0.0001 0.00 (0.00%)
As of 12:07 PM Eastern

SSKN vs. UTRS, MOTS, DRTSW, BDMDW, and COCHW

Should you buy Strata Skin Sciences stock or one of its competitors? Strata Skin Sciences's main competitors and comparable companies include Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Baird Medical Investment (BDMDW), and Envoy Medical (COCHW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Strata Skin Sciences compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.

32.4% of Strata Skin Sciences shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by company insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Given Minerva Surgical's higher possible upside, research analysts clearly believe Minerva Surgical is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Minerva Surgical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Minerva Surgical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Minerva Surgical's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Strata Skin Sciences -35.64%-476.73%-33.49%

Strata Skin Sciences has lower revenue, but higher earnings than Minerva Surgical. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

Minerva Surgical has a beta of 2.41, suggesting that its share price is 141% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of 0.04, suggesting that its share price is 96% less volatile than the broader market.

In the previous week, Strata Skin Sciences had 1 more articles in the media than Minerva Surgical. MarketBeat recorded 1 mentions for Strata Skin Sciences and 0 mentions for Minerva Surgical. Minerva Surgical's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Strata Skin Sciences Neutral

Summary

Strata Skin Sciences beats Minerva Surgical on 7 of the 13 factors compared between the two stocks.

How does Strata Skin Sciences compare to Motus GI?

Strata Skin Sciences (NASDAQ:SSKN) and Motus GI (NASDAQ:MOTS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends and valuation.

Strata Skin Sciences has higher revenue and earnings than Motus GI. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A
Motus GI$319K0.00-$12.87M-$14.69N/A

Strata Skin Sciences has a beta of 0.04, indicating that its share price is 96% less volatile than the broader market. Comparatively, Motus GI has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market.

Given Motus GI's higher possible upside, analysts plainly believe Motus GI is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Motus GI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Motus GI has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Motus GI's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Skin Sciences-35.64% -476.73% -33.49%
Motus GI N/A N/A N/A

In the previous week, Strata Skin Sciences had 1 more articles in the media than Motus GI. MarketBeat recorded 1 mentions for Strata Skin Sciences and 0 mentions for Motus GI. Strata Skin Sciences' average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company Overall Sentiment
Strata Skin Sciences Neutral
Motus GI Neutral

32.4% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 20.1% of Motus GI shares are owned by institutional investors. 40.9% of Strata Skin Sciences shares are owned by insiders. Comparatively, 0.3% of Motus GI shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Strata Skin Sciences beats Motus GI on 7 of the 13 factors compared between the two stocks.

How does Strata Skin Sciences compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Strata Skin Sciences (NASDAQ:SSKN) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

32.4% of Strata Skin Sciences shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Alpha Tau Medical has higher earnings, but lower revenue than Strata Skin Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

Alpha Tau Medical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Alpha Tau Medical's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Strata Skin Sciences -35.64%-476.73%-33.49%

In the previous week, Alpha Tau Medical had 2 more articles in the media than Strata Skin Sciences. MarketBeat recorded 3 mentions for Alpha Tau Medical and 1 mentions for Strata Skin Sciences. Alpha Tau Medical's average media sentiment score of 0.62 beat Strata Skin Sciences' score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Strata Skin Sciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Alpha Tau Medical beats Strata Skin Sciences on 5 of the 9 factors compared between the two stocks.

How does Strata Skin Sciences compare to Baird Medical Investment?

Strata Skin Sciences (NASDAQ:SSKN) and Baird Medical Investment (NASDAQ:BDMDW) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

Baird Medical Investment has lower revenue, but higher earnings than Strata Skin Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A
Baird Medical Investment$22.54MN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Baird Medical Investment
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Baird Medical Investment has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Baird Medical Investment's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Skin Sciences-35.64% -476.73% -33.49%
Baird Medical Investment N/A N/A N/A

32.4% of Strata Skin Sciences shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Baird Medical Investment had 1 more articles in the media than Strata Skin Sciences. MarketBeat recorded 2 mentions for Baird Medical Investment and 1 mentions for Strata Skin Sciences. Baird Medical Investment's average media sentiment score of 0.43 beat Strata Skin Sciences' score of 0.00 indicating that Baird Medical Investment is being referred to more favorably in the news media.

Company Overall Sentiment
Strata Skin Sciences Neutral
Baird Medical Investment Neutral

Summary

Baird Medical Investment beats Strata Skin Sciences on 5 of the 9 factors compared between the two stocks.

How does Strata Skin Sciences compare to Envoy Medical?

Envoy Medical (NASDAQ:COCHW) and Strata Skin Sciences (NASDAQ:SSKN) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.

Envoy Medical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Envoy Medical's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Envoy MedicalN/A N/A N/A
Strata Skin Sciences -35.64%-476.73%-33.49%

In the previous week, Envoy Medical and Envoy Medical both had 1 articles in the media. Envoy Medical's average media sentiment score of 1.89 beat Strata Skin Sciences' score of 0.00 indicating that Envoy Medical is being referred to more favorably in the media.

Company Overall Sentiment
Envoy Medical Very Positive
Strata Skin Sciences Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envoy Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Envoy Medical has higher earnings, but lower revenue than Strata Skin Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envoy Medical$207KN/AN/AN/AN/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

32.4% of Strata Skin Sciences shares are owned by institutional investors. 40.9% of Strata Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Envoy Medical and Strata Skin Sciences tied by winning 4 of the 8 factors compared between the two stocks.

Get Strata Skin Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSKN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SSKN vs. The Competition

MetricStrata Skin SciencesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1K$5.95B$7.06B$13.10B
Dividend YieldN/A1.76%2.57%10.45%
P/E Ratio0.0026.22269.0625.28
Price / Sales0.0063.09602.4391.76
Price / CashN/A33.9270.4850.90
Price / Book0.006.1012.916.24
Net Income-$10.09M$148.67M$3.45B$347.60M
7 Day PerformanceN/A1.84%1.12%1.07%
1 Month PerformanceN/A4.56%1.79%1.03%
1 Year PerformanceN/A8.67%67.69%20.77%

Strata Skin Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SSKN
Strata Skin Sciences
0.1134 of 5 stars
$0.00
flat
N/A-100.0%$1K$30.98MN/A120
UTRS
Minerva Surgical
N/A$0.00
flat
N/AN/A$1K$51.69MN/A160
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
DRTSW
Alpha Tau Medical
N/A$3.88
-0.3%
N/A+1,340.7%$0.00N/AN/A80
BDMDW
Baird Medical Investment
N/A$0.05
flat
N/A-51.2%$0.00$22.54MN/AN/A

Related Companies and Tools


This page (NASDAQ:SSKN) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners